Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Octapharma Plasma Inc.
483
•Octapharma Plasma Inc.•June 5, 2025

Octapharma Plasma Inc. – FDA 483, Jun 5, 2025

Record Details

An FDA inspection of Octapharma Plasma Inc., a source plasma collection establishment, took place from May 30, 2025, to June 5, 2025. The inspection resulted in two key observations, highlighting areas needing improvement in the company's operations under the Federal Food, Drug, and Cosmetic Act.

The primary observation noted the firm's failure to adequately determine donor eligibility before plasma collection. Specifically, the company did not assess donors for irregular pulses on the day of donation. Furthermore, donors whose pre-donation blood pressure (outside 90-180 mm Hg systolic or 50-100 mm Hg diastolic) or pulse rate (outside 50-100 beats per minute) fell outside acceptable ranges were neither deferred nor referred to a physician, potentially impacting donor safety.

The second observation concerned procedural documentation. The standard operating procedures lacked written descriptions for essential donor qualifying tests and measurements, including acceptable minimum and maximum values. This specifically applied to the assessment of irregular pulses. To address these findings, Octapharma Plasma Inc. is expected to implement corrective actions, ensuring robust donor screening processes and comprehensive, compliant procedural documentation to meet regulatory standards and safeguard public health.

Company
Octapharma Plasma Inc.
Inspection date
June 5, 2025
Product type
biologics
Office
San Francisco District Office
Person
  • Shelley H. Beausoleil
View Company Profile

ID · a7f61e4f-1a95-4e41-a6f8-da8930a91a71

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Octapharma Plasma Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.